RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM

Clinical trials for RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM trials appear

Sign up with your email to follow new studies for RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with devastating brain cancer: first human trial of promising drug begins

Disease control Recruiting now

This is a first-in-human study to find the safest dose of a new oral drug called ONC206 for children and young adults with aggressive brain tumors, including a type called diffuse midline glioma (DMG). The trial will test the drug alone or in combination with radiation therapy in…

Matched conditions: RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM

Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM

Get alerted when new RECURRENT MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM trials appear

New hope for kids with devastating brain cancer: first human trial of promising drug begins